- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Technology recognized as ground-breaking innovation within the medical device sector with significant market potential
T2 Biosystems, Inc., a company developing the first point-of-care medical diagnostic products that enable rapid molecular and immunodiagnostic testing on a single instrument, today announced it has won the MedTECH IGNITE Innovative Technology Competition, an award that that honors a ground-breaking medical device innovation with outstanding market potential.
T2 Biosystems will receive the award, sponsored by Manta Product Development, Inc., at the MassMEDIC Investors Conference today at the U Mass Boston Campus Center.
"We are honored to receive this award, which acknowledges the breakthrough potential of T2 Biosystems' revolutionary technology that eliminates extensive sample preparation for medical diagnostics," said John McDonough, CEO of T2 Biosystems. "This award recognizes the vision of T2's founders, as well as the innovation and scientific breakthroughs created by our world-class scientists and engineers."
T2 Biosystems is developing the next generation of medical diagnostic products through its proprietary technology, which combines nanotechnology and the miniaturization of proven magnetic resonance (MR) technology. T2 Biosystems' diagnostics are poised to offer improved speed, accuracy and efficiency as well as portability to a broader range of settings including doctor's offices, homes and hospitals.
T2 Biosystems' technology has been validated in multiple published journal articles and has accurately analyzed viruses, bacteria, proteins, hormones, DNA, small molecules and other diagnostic targets. The Company is developing a pipeline of diagnostic products based on its technology, including devices for hospitals, diagnostic laboratories and medical offices, as well as individual patients.
For more information, please click here
The Yates Network
Copyright © T2 BiosystemsIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Leti Announces Launch of First European Nanomedicine Characterisation Laboratory: Project Combines Expertise of 9 Partners in 8 Countries to Foster Nanomedicine Innovation and Facilitate Regulatory Approval July 1st, 2015
Engineering the world’s smallest nanocrystal July 2nd, 2015
Newly-Developed Biosensor in Iran Detects Cocaine Addiction June 23rd, 2015